Skip to main content

Intercure Ltd.

INCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001857030

No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Intercure Ltd. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of INCR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders1518+3
Shares2.95M4.06M+1.11M (+37.8%)
Value$9.75M$8.29M−$1.46M (−15.0%)

New holders (5)

Institutions that held Intercure Ltd. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to INCR in Q1 2023
InstitutionSharesValue% of portfolio
ETF Managers Group, LLC811,283$1.66M0.05%
Millennium Management LLC51,237$105.0K0.00%
Renaissance Technologies LLC44,687$91.0K0.00%
Virtu Financial LLC16,796$34.0K0.00%
Simplex Trading, LLC100$00.00%

Sold out (2)

Institutions that held Intercure Ltd. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of INCR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Toronto Dominion Bank198$1.00K
Royal Bank of Canada317$1.00K